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Abstract In regions of high bone loading, the mechano-
responsive osteocytes inhibit osteoclastic bone resorption
by producing signaling molecules. One possible candidate
is matrix extracellular phosphoglycoprotein (MEPE)
because acidic serine- and aspartate-rich MEPE-associated
motif peptides upregulate osteoprotegerin (OPG) gene
expression, a negative regulator of osteoclastogenesis.
These peptides are cleaved from MEPE when relatively
more MEPE than PHEX (phosphate-regulating gene with
homology to endopeptidases on the X chromosome) is
present. We investigated whether mechanical loading of
osteocytes affects osteocyte-stimulated osteoclastogenesis
by involvement of MEPE. MLO-Y4 osteocytes were
mechanically loaded by 1-h pulsating ﬂuid ﬂow (PFF;
0.7 ± 0.3 Pa, 5 Hz) or kept under static control conditions.
Recombinant MEPE (0.05, 0.5, or 5 lg/ml) was added to
some static cultures. Mouse bone marrow cells were seeded
on top of the osteocytes to determine osteoclastogenesis.
Gene expression of MEPE, PHEX, receptor activator of
nuclear factor kappa-B ligand (RANKL), and OPG by
osteocytes was determined after PFF. Osteocytes supported
osteoclast formation under static control conditions. Both
PFF and recombinant MEPE inhibited osteocyte-stimulated
osteoclastogenesis. PFF upregulated MEPE gene expres-
sion by 2.5-fold, but not PHEX expression. PFF decreased
the RANKL/OPG ratio at 1-h PFF treatment. Our data
suggest that mechanical loading induces changes in gene
expression by osteocytes, which likely contributes to the
inhibition of osteoclastogenesis after mechanical loading of
bone. Because mechanical loading upregulated gene
expression of MEPE but not PHEX, possibly resulting in
the upregulation of OPG gene expression, we speculate
that MEPE is a soluble factor involved in the inhibition of
osteoclastogenesis by osteocytes.
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Bone is a specialized connective tissue that tolerates
mechanical loads derived from weight bearing and from
muscle contractions [1]. Repeated loads lead to micro-
damage, which could cause fractures. Therefore, bone is
continuously remodeled by osteoclasts and osteoblasts that
act in a coordinated fashion [2]. First osteoclasts resorb
existing bone tissue, and subsequently osteoblasts reﬁll the
gap with new bone tissue. The actions of the osteoblasts
and osteoclasts are coordinated by the osteocytes [3–5].
Osteocytes are buried in the bone matrix and are in contact
with neighboring osteocytes via long slender cell pro-
cesses, located in canaliculi, which are ﬁlled with peri-
cellular interstitial ﬂuid. These cell processes make direct
cell–cell contact not only to neighboring osteocytes, but
also to osteoclasts and osteoclast precursors in bone mar-
row [1]. The three-dimensional network of interconnected
cells is present throughout bone. This osteocyte network
with its accompanying lacuno-canalicular porosity is likely
the site of mechanosensing in bone [2]. In the absence of
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tial ﬂuid occurs, leading to a lack of ﬂuid shear stress [2].
Tatsumi et al. [6] have shown that osteocytes produce pro-
osteoclastogenic signals in the absence of mechanical
loading leading to stimulation of bone resorption. Alter-
natively, mechanically loaded osteocytes may produce
factors that inhibit osteoclast recruitment, while under
disuse conditions osteocytes decrease the production of
osteoclast-inhibiting signals [2, 3].
Osteoclasts are multinucleated cells that arise from
hemopoietic cells of the monocyte/macrophage lineage [7].
Osteoclast formation in vivo is thought to be induced by
direct cell–cell contact of preosteoblastic/stromal cells with
monocyte/macrophage osteoclast precursors [7]. Osteoblast
lineage cells secrete key molecules responsible for osteo-
clast differentiation, i.e., receptor activator of nuclear
factor kappa-B ligand (RANKL) and macrophage colony-
stimulating factor (M-CSF). RANKL stimulates osteoclast
precursors to commit to the osteoclastic phenotype by
binding to its receptor, receptor activator of nuclear factor
kappa B (RANK), on the surface of osteoclast precursors
[8]. RANKL exists in two forms, a soluble form and a
membrane-bound form thought to be responsible for initi-
ating osteoclast formation. RANKL activity is negatively
regulated by osteoprotegerin (OPG), which competes with
RANK as a soluble receptor. OPG, like RANKL, is pro-
duced by cells of the osteoblast lineage [8]. Osteoclast
differentiation is inhibited when OPG is relatively more
upregulated than RANKL. Thus, the ratio of RANKL to
OPG determines osteoclastogenesis [9].
Osteoclastogenesis from mouse bone marrow cells is
inhibited by the addition of conditioned medium from
mechanically loaded MLO-Y4 osteocytes [3]. Osteocytes
can support osteoclastogenesis when co-cultured with
RAW264.7 monocyte osteoclast precursor cells, but
mechanical loading of osteocytes decreases their osteo-
clastogenic potential [5]. Soluble factors released by
mechanically loaded osteocytes inhibit osteoclastogenesis
induced by stromal cells or osteocytes [5]. Osteocytes
release RANKL and OPG molecules that regulate osteo-
clastogenesis. The RANKL/OPG ratio is decreased in
mechanically loaded osteocytes compared to nonloaded
controls, resulting in inhibition of osteoclastogenesis [5]. It
is largely unknown which signaling molecules that are
produced by osteocytes in response to mechanical loading
can modulate the RANKL/OPG ratio to inhibit osteo-
clastogenesis. One likely candidate is matrix extracellular
phosphoglycoprotein (MEPE).
MEPE is predominantly expressed by osteocytes in
human bone, with signiﬁcant expression by osteocytes
within mineralized bone [10]. MEPE mRNA and protein
expression in osteocytes is highly responsive to mechanical
loading of bone in vivo in a mouse tooth movement model
[11]. Synthetic 23mer peptide fragment of MEPE (AC-100,
region 242–264) containing the RGD (Arg-Gly-Asp) inte-
grin binding sequence and SGDG (Ser-Gly-Asp-Gly) gly-
cosaminoglycan-attachment sequence stimulates new bone
formation in vitro and in vivo [12]. MEPE serum levels in
healthy adult humans vary between 0.02 and 1.3 lg/ml.
Serum MEPE levels are high when bone mineral density is
high and low in aged individuals when bone mineral den-
sity is low, suggesting a physiological role of MEPE in
bone homeostasis [13]. MEPE protein is most likely
cleaved by a cathepsin B–like protease to a highly phos-
phorylated C-terminal acidic serine- and aspartate-rich
MEPE-associated motif (ASARM) peptide in osteocytes.
ASARM peptides are cleaved from MEPE when relatively
more MEPE than PHEX (phosphate-regulating gene with
homology to endopeptidases on the X chromosome) is
present. ASARM peptides increase the expression of OPG,
a negative regulator of osteoclastogenesis, in bone marrow
stromal cells [14]. MEPE might therefore be an important
signaling molecule involved in the regulation of osteoblast
and osteoclast activity during bone remodeling. The aim of
this study was to investigate whether mechanical loading of
osteocytes affects osteocyte-stimulated osteoclastogenesis
by involvement of MEPE.
Materials and Methods
Cell Culture
MLO-Y4 osteocytes (provided by Dr. Bonewald, San
Antonio, TX) [15] were cultured to near conﬂuence in
75-cm
2 culture ﬂasks with a minimal essential medium
(a-MEM) supplemented with 5% fetal bovine serum
(FBS; Gibco, Grand Island, NY), 5% calf serum (Gibco),
1.25 lg/ml Fungizone (Gibco), 150 lg/ml penicillin
(Sigma, St. Louis, MO), and 125 lg/ml streptomycin
(Sigma) at 37C and 5% CO2 in air.
Mouse bone marrow cells were used for the osteoclast
formation assay. Brieﬂy, 8-week-old male mice (C57BL/
6 J) were killed with a peritoneal injection of a lethal dose
of Euthesate (8 mg sodium pentobarbital per mouse; Sanoﬁ
Sante ´ Animale Benelux, Maassluis, The Netherlands). The
animal committee of the VU University Amsterdam
approved the use of mice in these experiments. Tibiae were
collected and soft tissue removed. Cleaned tibiae were then
ground in a mortar with a-MEM (Gibco) supplemented
with 10% FBS, 150 lg/ml penicillin, 125 lg/ml strepto-
mycin, 1.25 lg/ml Fungizone, and heparin (170 IU/ml;
Leo Pharmaceutical Products, Weesp, The Netherlands).
The cell suspension was aspirated through a 21-gauge
needle and ﬁltered with a 100-lm-pore-size Cell Strainer
ﬁlter (Falcon/Becton Dickinson, Franklin Lakes, NJ). Cells
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123were then washed twice in culture medium and centrifuged
for 10 min at 2009g, and 1 9 10
6 cells/cm
2 were seeded
on top of mechanically loaded or static MLO-Y4
osteocytes.
Pulsatile Fluid Flow
MLO-Y4 osteocytes between passages 30 and 31 were
collected with 0.25% trypsin (Difco Laboratories, Detroit,
MI) and 0.1% EDTA (ethylenediaminetetraacetic acid;
Sigma) in phosphate-buffered saline (PBS), and seeded at
1 9 10
3 cells/cm
2 on polylysine-coated (50 lg/ml; poly-L-
lysine hydrobromide; Sigma) glass slides (15 cm
2)i n
a-MEM with 5% FBS, 5% calf serum, and antibiotics.
They were incubated overnight at 37C with 5% CO2 in air,
then subjected to mechanical loading for 1 h by pulsating
ﬂuid ﬂow (PFF) or kept under static control conditions.
PFF at 5-Hz pulse frequency was generated by pumping
13 ml of culture medium in a pulsatile manner through a
parallel-plate ﬂow chamber (65 9 24 9 0.3 mm) contain-
ing the bone cells [16]. The mean applied ﬂuid shear stress
was 0.7 Pa with a pulse amplitude of 0.3 Pa, and the
estimated peak stress rate was 8.4 Pa/s [17–19]. Control
cultures were kept under stationary conditions in a petri
dish containing 13 ml ﬂow medium under similar condi-
tions as the experimental cultures, i.e., at 37Ci na
humidiﬁed atmosphere of 5% CO2 in air. After 1-h PFF or
static control treatment, cells were postincubated without
PFF for 1 or 6 h in 13 ml of fresh medium. After 1-h PFF
and at the end of each postincubation period, cells were
lysed for total RNA isolation as described below.
Osteoclast Formation
MLO-Y4 osteocytes seeded at 1 9 10
3 cells/cm
2 on glass
slides were either mechanically loaded by 1-h PFF
(0.7 ± 0.3 Pa, 5 Hz) or kept under static culture condi-
tions. A total of 1 9 10
6 bone marrow cells/cm
2 were
seeded on top of mechanically loaded or static MLO-Y4
osteocytes. They were kept in co-culture in a-MEM (Gib-
co) supplemented with 10% FBS, 150 lg/ml penicillin,
125 lg/ml streptomycin, and 1.25 lg/ml Fungizone. Cul-
ture medium was refreshed after 3 days. After 7 days of
co-culture, cells were ﬁxed in 4% formaldehyde in PBS for
10 min. Fixed cells were washed with PBS and stained for
tartrate-resistant acid phosphatase (TRACP) according to
the manufacturer’s instructions (Sigma). The number of
TRACP-positive multinucleated (three or more nuclei per
cell) and mononuclear cells were counted with a Leica DM
IL microscope (Leica, Wetzlar, Germany) equipped with a
920 objective.
In a well-established monoculture osteoclastogenesis
assay [3], bone marrow cells were seeded at 3 9 10
5 cells/cm
2
in 96-well plates in medium containing 30 ng/ml recom-
binant murine M-CSF (R&D Systems, Minneapolis, MN),
20 ng/ml recombinant murine RANKL (RANKL-TEC;
R&D Systems), and 20, 24, 50, 60, or 75 ng/ml recombi-
nant human OPG (Biovision, Mountain View, CA). Culture
medium containing M-CSF, RANKL, and OPG was
refreshed after 3 days. After 6 days of culture, cells were
ﬁxed, and TRACP-positive multinucleated cells were
counted as described above.
Effect of Recombinant MEPE on Osteoclast Formation
MLO-Y4 osteocytes were seeded at 1 9 10
3 cells/well in
48-well tissue culture plate. After overnight attachment,
osteocytes were treated for 24 h with 0.05, 0.5, or 5 lg/ml
of recombinant human MEPE (R&D Systems). A total of
1 9 10
6 bone marrow cells were seeded on top of recom-
binant human MEPE treated osteocytes. Co-culture was
maintained in the presence of 0.05, 0.5, or 5 lg/ml
recombinant human MEPE. After 7 days of co-culture, the
number of TRACP-positive multinucleated and mononu-
clear cells was determined.
Analysis of Gene Expression
Real-time polymerase chain reaction was used to determine
gene expression of MEPE, PHEX, RANKL, OPG, and the
housekeeping gene GAPDH (all primers from Applied
Biosystems, Foster City, CA). Total RNA was isolated
with lysis buffer RA I (Macherey-Nagel, Du ¨ren, Germany)
according to the manufacturer’s instructions. cDNA syn-
thesis was performed with 0.5–1 lg of total RNA in a
20-ml reaction mixture consisting of 5 units of Transcriptor
Reverse Transcriptase (Roche Diagnostics, Mannheim,
Germany), 0.08 A260 units of random primers (Roche
Diagnostics), 1 mmol/l of each dNTP (Invitrogen, Carls-
bad, CA), and 19 concentrated Transcriptor RT reaction
buffer (Roche Diagnostics). Real-time polymerase chain
reaction reactions were performed with Taq-Man Gene
Expression assays (TaqMan; Applied Biosystems) in an
ABI Prism 7700 DNA sequence detector (Applied Bio-
systems). Gene expression values were normalized for
housekeeping gene GAPDH.
Statistical Analysis
The Wilcoxon signed rank test was used for comparing the
effect of mechanically loaded osteocytes and static osteo-
cytes on the number of TRACP positive multinucleated
cells. For statistical analysis of the data obtained from all
other experiments, the paired Student’s t-test was used.
Differences were considered signiﬁcant when P\0.05.
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123Results
Osteocytes Support Osteoclast Formation from Bone
Marrow Cells
Mouse bone marrow cells co-cultured on top of MLO-Y4
osteocytes for 7 days fused to form TRACP-positive
multinucleated cells (TRACP
? MNCs) and mononuclear
cells (Fig. 1a).
Mechanical Loading of Osteocytes Inhibits
Osteoclastogenesis from Bone Marrow Cells
Next, we investigated the effect of mechanical loading on
osteoclast formation in a co-culture system of MLO-Y4
osteocytes and bone marrow cells. Osteocytes subjected to
1-h PFF stopped the formation of osteoclasts, as assessed
by the number of TRACP
? MNCs after 7 days of co-cul-
ture (Fig. 1b). One-hour PFF signiﬁcantly inhibited the
number of TRACP
? MNCs (Fig. 1c) and mononuclear
cells (Fig. 1d) compared to static conditions.
PFF Affects MEPE but not PHEX Gene Expression
To assess whether mechanical loading affects MEPE and
PHEX gene expression, MLO-Y4 osteocytes were treated
with or without 1-h PFF. Mechanical loading signiﬁcantly
upregulated MEPE gene expression by 2.5-fold after 1-h
PFF, but not at 1 or 6 h after termination of PFF (Fig. 2a).
PFF did not affect PHEX gene expression after 1-h PFF
treatment, nor at 1 or 6 h after termination of PFF (Fig. 2b).
This suggests that MEPE was relatively more upregulated
than PHEX.
Role of OPG and RANKL in PFF-stimulated
Osteoclastogenesis
To determine whether PFF affects osteoclastogenesis-
related gene expression, we analyzed gene expression of
RANKL, OPG, and M-CSF in MLO-Y4 osteocytes after 1-h
PFF. We found that PFF did not affect M-CSF gene
expression after 1-h PFF (data not shown). PFF upregulated
RANKL gene expression by 1.8-fold after 1-h PFF treat-
ment (Fig. 3a). Similarly, PFF upregulated OPG gene
expression by 2.1-fold after 1-h PFF treatment (Fig. 3a).
As a result, PFF decreased the RANKL/OPG ratio by 20%
after 1-h PFF treatment (Fig. 3b). To determine whether a
20% change in the RANKL/OPG ratio affects osteoclasto-
genesis, we stimulated mouse bone marrow stromal cells
with M-CSF and RANKL in the presence of different
concentrations of OPG. We found that OPG dose depen-
dently inhibited the number of TRACP
? MNCs (Fig. 3c).
Fig. 1 Mechanical loading of
osteocytes inhibits
osteoclastogenesis from bone




after 7 days of co-culture of
static MLO-Y4 osteocytes and
mouse bone marrow cells.
b MLO-Y4 osteocytes subjected
to 1-h PFF nihilized the
formation of TRACP-positive
multinucleated cells after 7 days
of co-culture with bone marrow
cells. Original magniﬁcation,
920. The number of c TRACP-
positive multinucleated and
d TRACP-positive mononuclear
cells was signiﬁcantly inhibited
due to 1-h PFF exposure of
MLO-Y4 osteocytes. Values are
means ± SEM from 3 separate
experiments. PFF pulsating
ﬂuid ﬂow, Static static control
cultures. * Signiﬁcant effect of
PFF, P\0.05
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ratio of 20% was already sufﬁcient to inhibit the number of
TRACP
? MNCs in our osteoclastogenesis assay (Fig. 3c).
Recombinant Human MEPE Inhibits Osteocyte-
stimulated Osteoclastogenesis
Mechanical loading of osteocytes with 1-h PFF signiﬁ-
cantly increased MEPE gene expression. We also studied
whether recombinant human MEPE could modulate oste-
ocyte-stimulated osteoclastogenesis. We found that MEPE
at 5 lg/ml inhibited the number of TRACP-positive
multinucleated cells (Fig. 4a) and TRACP-positive mono-
nuclear cells (Fig. 4b).
Discussion
Osteocytes are the predominant bone cells and the pro-
fessional mechanosensors of bone [2]. In response to
mechanical loading, osteocytes communicate with each
other and with other types of cells, including osteoblasts,
bone-lining cells, and osteoclasts, through the canalicular
network in which nutrients and other soluble factors are
Fig. 2 PFF treatment upregulates MEPE but not PHEX gene
expression by MLO-Y4 osteocytes. a PFF signiﬁcantly upregulated
MEPE gene expression after 1-h PFF, but not at 1 or 6 h after
termination of PFF. b PFF did not affect PHEX gene expression after
1-h PFF, or 1 and 6 h after termination of PFF. Data are expressed as
relative gene expression normalized for GAPDH gene expression.
Values are means ± SEM from 4 separate experiments. PFF
pulsating ﬂuid ﬂow, Static static control cultures. ** Signiﬁcant
effect of PFF, P\0.01




RANKL and OPG gene
expression after 1-h PFF
treatment. b PFF down-
regulated the RANKL/OPG ratio
after 1-h PFF treatment. c Effect





multinucleated cells. A 20%
decrease in the RANKL/OPG
ratio (OPG increased from
20 ng/ml to 24 ng/ml) was
already sufﬁcient to inhibit the
number of TRACP-positive
multinucleated cells. Values are
means ± SEM from 3 or more
separate experiments. PFF
pulsating ﬂuid ﬂow, Static static
control cultures. * Signiﬁcant
effect of PFF, P\0.05
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123transported by ﬂuid ﬂow. Osteocytes are therefore con-
sidered to be the orchestrators of bone adaptation to
mechanical loading [1–4].
Bone resorption is suppressed in response to mechanical
loading of bone in vivo [20, 21]. We have shown earlier
that conditioned medium from osteocytes subjected to PFF
inhibits osteoclast formation and function [3]. It was,
however, not demonstrated which molecules in the condi-
tioned medium were responsible for the inhibitory effect on
osteoclast formation and function. One of the molecules in
conditioned medium responsible for the inhibitory effect
could be MEPE. MEPE
-/- mice have a marked age
dependent increased bone mass and increased in vivo
mineral apposition rate without any effect on osteoclast
number [22]. In contrast, overexpression of MEPE
decreased osteoclast number and activity in a murine
model [23]. The purpose of the current study was to
investigate whether mechanical loading of osteocytes
affects osteocyte-stimulated osteoclastogenesis by
involvement of MEPE.
Osteocytes extend cell processes into bone marrow
space [24]. It is likely that osteocytes communicate directly
with the osteoclast precursors in the bone marrow space via
dendritic processes. Humoral factors produced by osteo-
cytes are released through the canaliculi into the bone
marrow space, where they may regulate the differentiation
and activity of osteoclasts. Therefore, we used a co-culture
model of MLO-Y4 osteocytes and mouse bone marrow
cells that likely mimics the in vivo situation. Recently,
Tatsumi et al. [6] showed that osteocyte-ablated mice
exhibit almost complete resistance to osteoclastic bone
resorption in response to unloading. These results indicate
that osteocytes play a crucial role in sensing the local
changes in mechanical strains evoked by unloading and/or
play a role in transmitting pro-osteoclastogenic signals to
stimulate bone resorption in response to mechanical
unloading [6]. On the other hand, osteocytes are known to
produce several factors in response to mechanical loading
that can inhibit osteoclastic bone resorption [3, 25].
Mechanical loading of osteocytes upregulates transforming
growth factor-b, which inhibits osteoclastic bone resorp-
tion as well [25]. Vascular endothelial growth factor, which
increases osteoclastogenesis in vitro [26], has also been
found to be increased after mechanical loading of primary
bone cells [27]. Osteocytes produce high levels of nitric
oxide in response to loading in the form of a physiologic
ﬂuid shear stress [28, 29], and nitric oxide inhibits osteo-
clast activity [3, 30]. Thus, osteocytes have different ways
to modulate osteoclastogenesis and osteoclast activity, and
MEPE could be one of those several factors produced in
response to mechanical loading by osteocytes modulating
osteoclastogenesis and osteoclast activity.
Osteocytes transduce opposite signals depending on the
nature and direction of mechanical input, i.e., an anti-
osteoclastogenic signal (under normal loading) versus a
pro-osteoclastogenic signal (in response to unloading) [6].
In our study, we found that osteocytes support osteoclast
formation under static culture conditions, whereas
mechanical loading of osteocytes by PFF signiﬁcantly
inhibited the formation of osteoclasts from bone marrow
cells. This is consistent with previous ﬁndings that
mechanical loading of MLO-Y4 osteocytes inhibits osteo-
clast formation from RAW264.7 mouse monocytes/mac-
rophages [5]. Mechanical loading of ST-2 murine stromal
bone marrow cells decreases osteoclastogenesis from
RAW264.7 cells through a decrease in the RANKL/OPG
ratio [31]. Osteoclasts in vivo are likely derived from
osteoclast precursors present in bone marrow spaces [32].
In our study, we used mouse bone marrow cells as a source
of osteoclast precursors. Here we show for ﬁrst time that
mechanical loading of osteocytes inhibits osteoclast for-
mation from bone marrow cells, which likely also occurs
in vivo.
Binding of PHEX to MEPE prevents cathepsin-medi-
ated cleavage of MEPE and the concomitant release of
ASARM peptide from MEPE [14]. We found that
Fig. 4 Effect of recombinant human MEPE on osteocyte-stimulated
osteoclastogenesis. Recombinant MEPE at 5 lg/mL dowregulated the
number of a TRACP-positive multinucleated cells, and b TRACP-
positive mononuclear cells after 7 days of co-culture of MLO-Y4
osteocytes and mouse bone marrow cells. Values are means ± SEM
from 3 separate experiments. * Signiﬁcant effect of PFF, P\0.05
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MEPE but not PHEX gene expression. OPG gene expres-
sion has been shown to be signiﬁcantly increased in bone
marrow stromal cells incubated with ASARM-PO4 [14].
MEPE gene expression was relatively more upregulated
than PHEX gene expression. Assuming the changes in gene
expression reﬂect changes in protein expression, this would
make MEPE available for cathepsin cleavage to produce
ASARM peptides and thereby upregulate OPG. We sug-
gest that the loading-induced shift in the balance between
MEPE and PHEX expression by osteocytes was responsi-
ble for the loading-induced increase in OPG gene expres-
sion via the production of ASARM peptides. This could
explain our ﬁnding that mechanical loading of osteocytes
downregulated the RANKL/OPG ratio immediately after
PFF treatment. Because the changes in the RANKL/OPG
ratio after PFF were relatively small, we simulated the
PFF-induced changes in the RANKL/OPG ratio and stud-
ied the effect on osteoclastogenesis. We found that a
decrease in the RANKL/OPG ratio by 20% strongly
inhibited osteoclastogenesis, which suggests that the PFF-
induced inhibition of osteoclastogenesis can be attributed
to a loading-induced decrease in RANKL/OPG ratio.
Because we found that mechanical loading of osteo-
cytes by PFF upregulated MEPE but not PHEX gene
expression, we studied whether recombinant human
MEPE modulated osteocyte-stimulated osteoclastogenesis.
Importantly, the amount of MEPE protein present in
conditioned medium after PFF treatment of osteocytes
might not reﬂect the amount of MEPE protein seen by
osteoclast precursors in our co-culture model. We have
not used conditioned medium of osteocytes to inhibit
osteoclastogenesis, but osteoclast precursors were seeded
on top of osteocytes. The osteoclast precursors that were
thus in direct contact with the osteocytes were likely
exposed to high local MEPE protein concentrations.
Serum MEPE levels in healthy adult humans vary
between 0.02 and 1.3 lg/ml [13]. Because MEPE is
predominantly expressed by osteocytes in human bone, it
is likely that local MEPE levels in bone are even higher
than the serum MEPE levels in healthy adult humans.
We found that recombinant human MEPE inhibited oste-
ocyte-stimulated osteoclastogenesis, which is in accor-
dance with ﬁndings by others that recombinant human
MEPE decreases parathyroid hormone–related protein
and 1,25-dihydroxy vitamin D3-induced osteoclast for-
mation from mouse bone marrow cells [33]. Although we
cannot prove that MLO-Y4 cells produced MEPE at a
concentration of 0.05–5 lg/ml, it can be appreciated that
PFF upregulates MEPE gene expression in osteocytes,
and that recombinant MEPE can inhibit osteoclasto-
genesis at concentrations lower than the MEPE concen-
trations likely present in bone. Our results indicate that
MEPE may contribute to the mechanical loading-induced
inhibition of osteoclastogenesis.
In summary, osteocytes subjected to 1-h PFF signiﬁ-
cantly inhibited the formation of osteoclasts from bone
marrow cells. On the basis of our results, we speculate that
MEPE might be a soluble factor produced after mechani-
cal loading of osteocytes, leading to the inhibition of
osteoclastogenesis. This supports the regulatory role for
osteocytes in osteoclast formation and bone resorp-
tion. Increased understanding of communication between
mechanically loaded osteocytes and osteoclasts will help to
clarify bone remodeling in response to mechanical loading,
and it might contribute to new treatment modalities for
diseases where this communication might be disturbed,
such as osteoporosis or osteopetrosis. Thus, MEPE could
be a potential therapeutic agent for treatment of diseases
such as osteoporosis.
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